NEUROIMMUNOLOGICAL AND METABOLIC CORRELATION: A MULTIDIMENSIONAL REVIEW OF THE LINKS BETWEEN OBESITY AND ANXIETY DISORDERS

Julia Wawerska; Martyna Grzywacz; Łukasz Deska; Balbina Tybulczuk; Agata Kaczmarzyk; Weronika Zarzycka; Jakub Skrzypek; Natalia Fidut; Karol Szyprowski; Kamila Zioło

doi:10.31435/ijitss.2(50).2026.5163

Authors

Julia Wawerska Medical University of Lodz, Łódź, Poland https://orcid.org/0009-0006-0145-6204
Martyna Grzywacz Medical University of Lodz, Łódź, Poland https://orcid.org/0009-0002-4366-4379
Łukasz Deska 10th Military Clinical Hospital with Independent Public Healthcare Centre Polyclinic in Bydgoszcz, Bydgoszcz, Poland https://orcid.org/0009-0009-9593-7077
Balbina Tybulczuk Medical University of Lublin, Lublin, Poland https://orcid.org/0000-0002-2854-4697
Agata Kaczmarzyk Medical University of Lodz, Łódź, Poland https://orcid.org/0009-0005-7448-9827
Weronika Zarzycka 1st Military Clinical Hospital with the Outpatient Clinic, al. Racławickie 23, 20-049 Lublin, Poland https://orcid.org/0009-0004-1927-4076
Jakub Skrzypek Stefan Cardinal Wyszyński Provincial Specialist Hospital SPZOZ in Lublin, Al. Kraśnicka 100, 20-718 Lublin, Poland https://orcid.org/0009-0004-1155-5818
Natalia Fidut Stefan Cardinal Wyszyński Provincial Specialist Hospital SPZOZ in Lublin, Al. Kraśnicka 100, 20-718 Lublin, Poland https://orcid.org/0009-0006-2550-3933
Karol Szyprowski 1st Military Clinical Hospital with the Outpatient Clinic, al. Racławickie 23, 20-049 Lublin, Poland https://orcid.org/0009-0001-0336-6425
Kamila Zioło 1st Military Clinical Hospital with the Outpatient Clinic, al. Racławickie 23, 20-049 Lublin, Poland https://orcid.org/0009-0003-3875-4000

DOI:

https://doi.org/10.31435/ijitss.2(50).2026.5163

Keywords:

Obesity, Anxiety Disorders, Systemic Inflammation, HPA Axis, Gut Microbiota, Psychosomatics

Abstract

Contemporary clinical medicine faces two global health crises: obesity and anxiety disorders. Although historically treated as independent entities, contemporary epidemiology points to a clear correlation between them – the risk of anxiety disorders in obese individuals is significantly higher. The aim of this systematic review of the literature is to provide a comprehensive, multi-level analysis of the mechanisms linking excess body weight to anxiety disorders. The study hypothesises the existence of a "metabolic-anxiety vicious circle" mediated by chronic inflammation, hypothalamic-pituitary-adrenal axis dysfunction, and gut-brain axis disorders. An extensive review was conducted in the PubMed, Scopus, Web of Science and Google Scholar databases, covering publications from 2000 to 2025. The selection included cohort studies (e.g., NEMESIS-2, LifeLines), meta-analyses, and translational studies. Analysis of the scientific evidence allows us to identify four key pathophysiological pillars. Firstly, visceral obesity generates chronic low-grade inflammation, which induces neuroinflammation in limbic structures through the blood-brain barrier. Secondly, chronic anxiety leads to dysregulation of the hypothalamic-pituitary-adrenal axis and hypercortisolemia, causing visceral obesity. Thirdly, genetic variants have pleiotropic effects. Fourthly, intestinal dysbiosis is a new key mediator in the communication between metabolism and the psyche. Obesity and anxiety are not coincidental co-occurring phenomena, but are manifestations of a common dysregulation of the body's homeostasis. This implies the need to change existing treatment patterns to an integrated model that combines somatic treatment with psychotherapeutic treatment.

References

Kauffman, B. Y., Rogers, A. H., Garey, L., & Zvolensky, M. J. (2022). Anxiety and depressive symptoms among adults with obesity and chronic pain: The role of anxiety sensitivity. Cognitive Behaviour Therapy, 51(4), 295–308. https://doi.org/10.1080/16506073.2021.2011396

de Wit, L., ten Have, M., Cuijpers, P., & de Graaf, R. (2022). Body mass index and risk for onset of mood and anxiety disorders in the general population: Results from the Netherlands Mental Health Survey and Incidence Study-2 (NEMESIS-2). BMC Psychiatry, 22, Article 522. https://doi.org/10.1186/s12888-022-04077-w

Lappalainen, R., Sairanen, E., Järvelä, E., Rantala, S., Korpela, R., Puttonen, S., Kujala, U. M., Myllymäki, T., Peuhkuri, K., Mattila, E., Kaipainen, K., Ahtinen, A., Karhunen, L., Pihlajamäki, J., Järnefelt, H., Laitinen, J., Kutinlahti, E., Saarelma, O., Ermes, M., & Kolehmainen, M. (2014). The effectiveness and applicability of different lifestyle interventions for enhancing wellbeing: The study design for a randomised controlled trial for persons with metabolic syndrome risk factors and psychological distress. BMC Public Health, 14, Article 310. https://doi.org/10.1186/1471-2458-14-310

Bose, M., Oliván, B., & Laferrère, B. (2009). Stress and obesity: The role of the hypothalamic–pituitary–adrenal axis in metabolic disease. Current Opinion in Endocrinology, Diabetes and Obesity, 16(5), 340–346. https://doi.org/10.1097/MED.0b013e32832fa137

Cheng, T., Dimitrov, S., Pruitt, C., & Hong, S. (2016). Glucocorticoid-mediated regulation of inflammation in human monocytes is associated with depressive mood and obesity. Psychoneuroendocrinology, 66, 195–204. https://doi.org/10.1016/j.psyneuen.2016.01.008

Dalle Grave, R., Sartirana, M., & Calugi, S. (2020). Personalised cognitive-behavioural therapy for obesity (CBT-OB): Theory, strategies and procedures. BioPsychoSocial Medicine, 14, Article 5. https://doi.org/10.1186/s13030-020-00177-9

Crisp, A. H., & McGuiness, B. (1976). Jolly fat: Relation between obesity and psychoneurosis in general population. British Medical Journal, 1, 7–9. https://doi.org/10.1136/bmj.1.6000.7

Afzal, M., Siddiqi, N., Ahmad, B., Afsheen, N., Aslam, F., Ali, A., Ayesha, R., Bryant, M., Holt, R., Khalid, H., Ishaq, K., Koly, K. N., Rajan, S., Saba, J., Tirbhowan, N., & Zavala, G. A. (2021). Prevalence of overweight and obesity in people with severe mental illness: Systematic review and meta-analysis. Frontiers in Endocrinology, 12, Article 769309. https://doi.org/10.3389/fendo.2021.769309

Castanon, N., Lasselin, J., & Capuron, L. (2014). Neuropsychiatric comorbidity in obesity: Role of inflammatory processes. Frontiers in Endocrinology, 5, Article 74. https://doi.org/10.3389/fendo.2014.00074

Hallihan, H., Tsai, P., Lv, N., Xiao, L., Bernabé, B. P., Wu, Y., Pandey, G. N., Williams, L. M., Ma, J., & Ajilore, O. A. (2023). Affective neural circuits and inflammatory markers linked to depression and anxiety symptoms in patients with comorbid obesity. Journal of Psychiatric Research, 160, 9–18. https://doi.org/10.1016/j.jpsychires.2023.01.044

Mazzitelli, M., Trunfio, M., Milinković, A., Castelli, E., Sasset, L., Leoni, D., Salvucci, M., Cazzaro, R., Calcinoni, I., Balducci, P., Ribeiro, G. C. Q., Filagrana, G., Scaglione, V., & Cattelan, A. M. (2023). Sleep disturbances and their correlation with cardiovascular risk, obesity, and mood disorders in people with HIV. AIDS, 37(6), 925–934. https://doi.org/10.1097/QAD.0000000000003493

Walter, S., Glymour, M. M., Koenen, K., Liang, L., Tchetgen Tchetgen, E. J., Cornelis, M., Chang, S.-C., Rewak, M., Rimm, E., Kawachi, I., & Kubzansky, L. D. (2015). Do genetic risk scores for body mass index predict risk of phobic anxiety? Evidence for a shared genetic risk factor. Psychological Medicine, 45(1), 181–191. https://doi.org/10.1017/S0033291714001226

Luo, K., Zhang, M., Tu, Q., Li, J., Wang, Y., Wan, S., Li, D., Qian, Q., & Xia, L. (2025). From gut inflammation to psychiatric comorbidity: Mechanisms and therapies for anxiety and depression in inflammatory bowel disease. Journal of Neuroinflammation, 22(1), Article 149. https://doi.org/10.1186/s12974-025-03476-6

Aschbacher, K., Rodriguez-Fernandez, M., van Tmarschen, H., Tomiyama, A. J., Jain, S., Epel, E., Doyle, F. J., III, & van der Greef, J. (2014). The hypothalamic–pituitary–adrenal–leptin axis and metabolic health: A systems approach to resilience, robustness and control. Interface Focus, 4(5), Article 20140020. https://doi.org/10.1098/rsfs.2014.0020

Romero Garavito, A., Díaz Martínez, V., Juárez Cortés, E., Negrete Díaz, J. V., & Montilla Rodríguez, L. M. (2025). Impact of physical exercise on the regulation of brain-derived neurotrophic factor in people with neurodegenerative diseases. Frontiers in Neurology, 15, Article 1505879. https://doi.org/10.3389/fneur.2024.1505879

Luppino, F. S., de Wit, L. M., Bouvy, P. F., Stijnen, T., Cuijpers, P., Penninx, B. W. J. H., & Zitman, F. G. (2010). Overweight, obesity, and depression: A systematic review and meta-analysis of longitudinal studies. Archives of General Psychiatry, 67(3), 220–229. https://doi.org/10.1001/archgenpsychiatry.2010.2

Nigatu, Y. T., Reijneveld, S. A., de Jonge, P., van Rossum, E., & Bültmann, U. (2016). The combined effects of obesity, abdominal obesity and major depression/anxiety on health-related quality of life: The LifeLines Cohort Study. PLOS ONE, 11(2), Article e0148871. https://doi.org/10.1371/journal.pone.0148871

Cassin, S. E., Park, K., Leung, S. E., Ma, C., Tomlinson, G., Hawa, R., Wnuk, S., Jackson, T., Urbach, D., Okrainec, A., Brown, J., Sandre, D., & Sockalingam, S. (2025). A randomised-controlled trial examining telephone-based cognitive behavioural therapy for patients after metabolic and bariatric surgery: 18-month follow-up results. Obesity Surgery, 35, 4103–4113. https://doi.org/10.1007/s11695-025-08163-2

Vorokhta, Y. M., & Bieliaieva, N. V. (2023). Structure of anxiety disorders in patients with chronic migraine and abdominal obesity. Clinical and Preventive Medicine, (8), 52–58. https://doi.org/10.31612/2616-4868.8.2023.06

dos Santos Moraes, A., da Costa Padovani, R., La Scala Teixeira, C. V., Soria Cuesta, M. G., dos Santos Gil, S., de Paula, B., dos Santos, G. M., Gonçalves, R. T., Dâmaso, A. R., Oyama, L. M., Gomes, R. J., & Caranti, D. A. (2021). Cognitive behavioural approach to treat obesity: A randomised clinical trial. Frontiers in Nutrition, 8, Article 611217. https://doi.org/10.3389/fnut.2021.611217

Campbell, A. C., Calais-Ferreira, L., Hahn, E., Spinath, F. M., Hopper, J. L., & Young, J. T. (2024). Familial confounding of internalising symptoms and obesity in adolescents and young adults: A co-twin analysis. International Journal of Obesity, 48, 876–883. https://doi.org/10.1038/s41366-024-01491-w

Tkachenko, V., & Bagro, T. (2023). The correlation between body weight, serotonin levels, mental health status, sleep disorders and metabolism in patients with obesity. International Journal of Endocrinology (Ukraine), 19(5), 354–362. https://doi.org/10.22141/2224-0721.19.5.2023.1299

Savulescu-Fiedler, I., Mihalcea, R., Dragosloveanu, S., Scheau, C., Baz, R. O., Caruntu, A., Scheau, A.-E., Caruntu, C., & Benea, S. N. (2024). The interplay between obesity and inflammation. Life, 14(7), Article 856. https://doi.org/10.3390/life14070856

Lawlor, E. R., Islam, N., Bates, S., Griffin, S. J., Hill, A. J., Hughes, C. A., Sharp, S. J., & Ahern, A. L. (2020). Third-wave cognitive behaviour therapies for weight management: A systematic review and network meta-analysis. Obesity Reviews, 21(7), Article e13013. https://doi.org/10.1111/obr.13013

Yokoyama, H., Nozaki, T., Nishihara, T., Sawamoto, R., Komaki, G., & Sudo, N. (2022). Factors associated with the improvement of body image dissatisfaction of female patients with overweight and obesity during cognitive behavioural therapy. Frontiers in Psychiatry, 13, Article 1025946. https://doi.org/10.3389/fpsyt.2022.1025946

Guedes, E. P., Madeira, E., Mafort, T. T., Madeira, M., Moreira, R. O., Mendonça, L. M., Godoy-Matos, A. F., Lopes, A. J., & Farias, M. L. F. (2013). Body composition and depressive/anxiety symptoms in overweight and obese individuals with metabolic syndrome. Diabetology & Metabolic Syndrome, 5, Article 82. https://doi.org/10.1186/1758-5996-5-82

Loh, H. H., Francis, B., Lim, L. L., Yee, A., & Loh, H. S. (2021). Improvement in mood symptoms after post-bariatric surgery among people with obesity: A systematic review and meta-analysis. Diabetes/Metabolism Research and Reviews, 37(8), Article e3458. https://doi.org/10.1002/dmrr.3458

Henriques, J., Afreixo, V., Unterrainer, H., & Senra, H. (2025). Psychological mediators of the association between obesity and symptoms of depression, anxiety, and stress. Neuropsychobiology, 84(1), 26–37. https://doi.org/10.1159/000542767

Kennedy, J. T., Astafiev, S. V., Golosheykin, S., Korucuoglu, O., & Anokhin, A. P. (2019). Shared genetic influences on adolescent body mass index and brain structure: A voxel-based morphometry study in twins. NeuroImage, 199, 261–272. https://doi.org/10.1016/j.neuroimage.2019.05.053

Capuron, L., & Miller, A. H. (2011). Immune system to brain signalling: Neuropsychopharmacological implications. Pharmacology & Therapeutics, 130(2), 226–238. https://doi.org/10.1016/j.pharmthera.2011.01.014

Noble, E. E., Hsu, T. M., & Kanoski, S. E. (2017). Gut to brain dysbiosis: Mechanisms linking Western diet consumption, the microbiome, and cognitive impairment. Frontiers in Behavioral Neuroscience, 11, Article 9. https://doi.org/10.3389/fnbeh.2017.00009

Almutabagani, L. F., Almanqour, R. A., Alsabhan, J. F., Alhossan, A. M., Alamin, M. A., Alrajeh, H. M., Alonazi, A. S., El-Malky, A. M., & Alrasheed, N. M. (2023). Inflammation and treatment-resistant depression from clinical to animal study: A possible link? Neurology International, 15(1), 100–120. https://doi.org/10.3390/neurolint15010009

Scheen, A. J. (2025). Weight loss therapy and addiction: Increased risk after bariatric surgery but reduced risk with GLP-1 receptor agonists. Diabetes & Metabolism, 51(2), Article 101612. https://doi.org/10.1016/j.diabet.2025.101612